These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 28647684
1. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Mera RM, Bravo LE, Camargo MC, Bravo JC, Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG, Morgan DR, Peek RM, Correa P, Wilson KT, Piazuelo MB. Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684 [Abstract] [Full Text] [Related]
2. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions. Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM, Correa P, Wilson KT. Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252 [Abstract] [Full Text] [Related]
3. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ. Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578 [Abstract] [Full Text] [Related]
4. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y. PLoS One; 2021 Sep; 16(8):e0255601. PubMed ID: 34379655 [Abstract] [Full Text] [Related]
5. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. Liu KS, Wong IO, Leung WK. World J Gastroenterol; 2016 Jan 21; 22(3):1311-20. PubMed ID: 26811668 [Abstract] [Full Text] [Related]
14. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer. Cho SJ, Choi IJ, Kook MC, Yoon H, Park S, Kim CG, Lee JY, Lee JH, Ryu KW, Kim YW. Aliment Pharmacol Ther; 2013 Sep 21; 38(5):477-89. PubMed ID: 23822578 [Abstract] [Full Text] [Related]
15. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. Lu B, Chen MT, Fan YH, Liu Y, Meng LN. World J Gastroenterol; 2005 Nov 07; 11(41):6518-20. PubMed ID: 16425426 [Abstract] [Full Text] [Related]
16. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. J Natl Cancer Inst; 2000 Dec 06; 92(23):1881-8. PubMed ID: 11106679 [Abstract] [Full Text] [Related]
17. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Chen HN, Wang Z, Li X, Zhou ZG. Gastric Cancer; 2016 Jan 06; 19(1):166-75. PubMed ID: 25609452 [Abstract] [Full Text] [Related]
18. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. World J Gastroenterol; 2005 Feb 14; 11(6):791-6. PubMed ID: 15682469 [Abstract] [Full Text] [Related]
19. Long-term effects and benefits of Helicobacter pylori eradication on the gastric mucosa in older individuals. Chen J, Zhang G, Qin J, Huang Y, Wang Y, Li Z, Ji D, Xiao L, Yin S, Bao Z. Saudi J Gastroenterol; 2022 Feb 14; 28(2):149-156. PubMed ID: 35083971 [Abstract] [Full Text] [Related]